Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Tarsus Pharmaceuticals Inc have a median target of 66.50, with a high estimate of 84.00 and a low estimate of 41.00. The median estimate represents a 43.32% increase from the last price of 46.40.
High | 81.0% | 84.00 |
Med | 43.3% | 66.50 |
Low | -11.6% | 41.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | +16.03% |
Average growth rate | -91.65% |
More ▼
Revenue history & estimates in USD
Average growth rate | +193.94% |
Average growth rate | -43.57% |
More ▼